Medistim ASA
OSE:MEDI
Medistim ASA
Other Equity
Medistim ASA
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medistim ASA
OSE:MEDI
|
Other Equity
kr390.2m
|
CAGR 3-Years
208%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Lifecare AS
OSE:LIFE
|
Other Equity
-kr63.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Other Equity
kr115.6m
|
CAGR 3-Years
78%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
See Also
What is Medistim ASA's Other Equity?
Other Equity
390.2m
NOK
Based on the financial report for Dec 31, 2024, Medistim ASA's Other Equity amounts to 390.2m NOK.
What is Medistim ASA's Other Equity growth rate?
Other Equity CAGR 5Y
15%
Over the last year, the Other Equity growth was 1 477%. The average annual Other Equity growth rates for Medistim ASA have been 208% over the past three years , 15% over the past five years .
You don't have any saved screeners yet